Welcome to the new Regeneron Newsroom. This newsroom is designed to provide members of the media with easy access to up-to-date information about the Company. If you are a reporter with a question about Regeneron, please call our Media Line at (914) 847-7800.
For an e-mail response to questions about Regeneron, please contact us at media@regeneron.com .
May 10, 2012
Regeneron Announces Presentation at the Bank of America Merrill Lynch 2012 Healthcare Conference
May 9, 2012
Regeneron Announces Participation in J. P. Morgan Biotech: CEO/CFO Conference Call Series
May 8, 2012
Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
May 8, 2012
Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
Apr 26, 2012
Regeneron Reports First Quarter 2012 Financial and Operating Results
Apr 12, 2012
Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
Apr 5, 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept)
Mar 26, 2012
Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody
Mar 21, 2012
Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody
Mar 9, 2012
Regeneron Announces Change in Date for Presentation at Barclays Capital 2012 Global Healthcare Conference
Shareholder Briefcase
E-mail Alerts
Download Library
REGN Snapshot
RSS News Feeds
Bank of America Merrill Lynch 2012 Healthcare Conference
